Powered by HealthTechMovers.com
We added 3 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Amylyx Pharmaceuticals Inc, AMLX
Summary: Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.
- Last Price: $24.69
- Price Change: $0.65, 2.7%
- Yearly Gain: 170.42%
- Market Cap: $1.67B
- P/E Ratio: -15.51
Here are 3rd party ratings for AMLX:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 43% (108 out of 250)
What is the sentiment on the street regarding Amylyx Pharmaceuticals Inc ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: High
- Insider Signal: Negative
- Investor Sentiment: ―
- Hedge Fund signal: Very Negative
If you are interested in AMLX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on AMLX before you decide to make any investment.
Click here for chart >>
Freeline Therapeutics Holdings, FRLN
Summary: Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company. It is focused on AAV-based gene therapy targeting the liver. The company operates principally in Germany and the U.S. Freeline Therapeutics Holdings plc is headquartered in the U.K.
- Last Price: $2.51
- Price Change: $0.01, 0.4%
- Yearly Gain: -78.35%
- Market Cap: $10.86M
- P/E Ratio: -0.063
Here are 3rd party ratings for FRLN:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 41% (103 out of 250)
What is the sentiment on the street regarding Freeline Therapeutics Holdings ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: ―
- Media Buzz: Low
- Insider Signal: ―
- Investor Sentiment: ―
- Hedge Fund signal: Neutral
If you are interested in FRLN or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on FRLN before you decide to make any investment.
Click here for chart >>
PepGen Inc., PEPG
Summary: PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen Inc. is based in BOSTON.
- Last Price: $14.98
- Price Change: -$0.80, -5.07%
- Yearly Gain: 41.02%
- Market Cap: $363.63M
- P/E Ratio: -4.731
Here are 3rd party ratings for PEPG:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 41% (103 out of 250)
What is the sentiment on the street regarding PepGen Inc. ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Neutral
- Media Buzz: Medium
- Insider Signal: ―
- Investor Sentiment: ―
- Hedge Fund signal: Neutral
If you are interested in PEPG or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on PEPG before you decide to make any investment.
Click here for chart >>
Thanks for reading!